Kinsale Capital Stock Deep Dive w/ Clay Finck & Daniel Mahncke (TIP804)

Watch on YouTube ↗  |  April 02, 2026 at 22:45  |  1:15:27  |  We Study Billionaires

Summary

  • Kinsale Capital is a specialty insurer dominating the niche Excess & Surplus (E&S) market, which covers non-standard, hard-to-place risks (e.g., unique commercial liabilities, high-risk construction).
  • Its core advantage is a technology-driven, in-house underwriting model that enables high efficiency, rapid quoting, and accurate pricing for small premium accounts (avg. ~$15,000) that are uneconomical for larger competitors.
  • This operational edge results in exceptional profitability: a combined ratio of ~76% vs. industry avg. ~91%, and a return on equity of ~30%.
  • The company is founder-led (CEO Michael Kehoe) with strong incentive alignment; management owns significant equity and bonuses are tied to underwriting profit, ROE, and combined ratio.
  • Growth is structurally supported by the E&S market growing faster (~10.5% p.a.) than the standard P&C market, and Kinsale has only ~2% share of this ~$115B market.
  • Recent growth has decelerated (18% premium growth in 2025 vs. 36% avg. in prior 5 years) as the insurance cycle has softened from a prolonged "hard market."
  • Management is disciplined and will sacrifice growth to maintain underwriting profitability, likened to a "value investor in the insurance space."
  • Valuation has compressed significantly: P/E is ~18 and P/B is ~4.5x, down from a P/E over 40 three years ago, as growth has slowed and growth investors have exited.
  • Key risks include the cyclical nature of the E&S market, increased competition eroding high ROE, broker concentration (top 5 brokers account for >50% of volume), and key-person dependency on CEO Michael Kehoe.
Trade Ideas
Clay Finck Host, The FinTwit Podcast 2:00
The speaker details Kinsale's exceptional historical performance (37% annual compounding since IPO, ~30% ROE, 76% combined ratio), its durable competitive moats (technology, in-house underwriting, niche focus), and notes the stock is down ~30% from highs with valuation at more reasonable levels (P/E ~18, P/B ~4.5x). The company's unique model allows it to profitably serve a growing, underserved niche (E&S insurance). The recent valuation compression is attributed to cyclical slowing growth, not a deterioration of the competitive advantage, creating a potential entry point for a high-quality compounder. The combination of a best-in-class business model, aligned management, a long growth runway, and a significantly lower valuation presents a compelling long-term opportunity. A prolonged soft market cycle leads to intensified price competition, eroding underwriting margins and ROE faster than anticipated. Execution risk if the innovative culture erodes.
Up Next

This We Study Billionaires video, published April 02, 2026, features Clay Finck discussing KNSL. 1 trade idea extracted by AI with direction and confidence scoring.

Speakers: Clay Finck  · Tickers: KNSL